Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Candice Clarke

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Kidney International Reports|February 22, 2021
Serologic Screening for Coronavirus Disease 2019 in Patients With Glomerular DiseaseTabitha Turner-Stokes, Elina Jiang, Nathan Johnson, et al.
Wellcome Open Research|June 9, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody lateral flow assay for antibody prevalence studies following vaccination: a diagnostic accuracy studyAlexandra Cann, Candice Clarke, Jonathan Brown, et al.
Haematologica|January 21, 2018
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphomaZiduo Li, Xinsheng Ju, Kenneth Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 13, 2016
The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell PopulationXinsheng Ju, Pablo A Silveira, Wei-Hsun Hsu, et al.
Nature Medicine|July 6, 2023
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive diseaseEleanor Barnes, Carl S Goodyear, Michelle Willicombe, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Kidney International Reports|February 22, 2021
Serologic Screening for Coronavirus Disease 2019 in Patients With Glomerular DiseaseTabitha Turner-Stokes, Elina Jiang, Nathan Johnson, et al.
Wellcome Open Research|June 9, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody lateral flow assay for antibody prevalence studies following vaccination: a diagnostic accuracy studyAlexandra Cann, Candice Clarke, Jonathan Brown, et al.
Haematologica|January 21, 2018
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphomaZiduo Li, Xinsheng Ju, Kenneth Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 13, 2016
The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell PopulationXinsheng Ju, Pablo A Silveira, Wei-Hsun Hsu, et al.
Nature Medicine|July 6, 2023
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive diseaseEleanor Barnes, Carl S Goodyear, Michelle Willicombe, et al.
Pageof 4